Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Cash Flow Reinvestment Rate
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting CN¥21.06 Million (capex CN¥21.06 Million ) from operating cash flow of CN¥110.78 Million. Explore Tianjin Zhongxin Pharmaceutical Group Co (600329) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow Reinvestment Rate (2001–2024)
Historical reinvestment intensity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 22 annual periods. Also explore Tianjin Zhongxin Pharmaceutical Group Co (600329) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year capital reinvestment analysis for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For live market cap and broader valuation context, see 600329 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.00x | CN¥925.65 Million | CN¥924.67 Million | CN¥117.81 Million | ▼ -2.9% |
| 2023 | 1.03x | CN¥709.84 Million | CN¥688.49 Million | CN¥140.93 Million | ▲ +481.0% |
| 2022 | 0.18x | CN¥120.18 Million | CN¥677.25 Million | CN¥107.90 Million | ▼ -69.2% |
| 2021 | 0.58x | CN¥491.87 Million | CN¥852.40 Million | CN¥156.95 Million | ▲ +68.3% |
| 2020 | 0.34x | CN¥230.21 Million | CN¥671.42 Million | CN¥189.16 Million | ▼ -44.1% |
| 2019 | 0.61x | CN¥303.67 Million | CN¥495.49 Million | CN¥205.61 Million | ▼ -62.9% |
| 2018 | 1.65x | CN¥578.87 Million | CN¥350.14 Million | CN¥175.81 Million | ▲ +239.1% |
| 2016 | 0.49x | CN¥204.73 Million | CN¥419.90 Million | CN¥116.20 Million | ▼ -61.6% |
| 2015 | 1.27x | CN¥457.26 Million | CN¥360.58 Million | CN¥92.64 Million | ▲ +418.5% |
| 2014 | 0.24x | CN¥70.15 Million | CN¥286.85 Million | CN¥70.15 Million | ▼ -27.9% |
| 2013 | 0.34x | CN¥72.42 Million | CN¥213.44 Million | CN¥72.42 Million | ▼ -82.9% |
| 2012 | 1.98x | CN¥41.18 Million | CN¥20.81 Million | CN¥41.18 Million | ▲ +699.8% |
| 2011 | 0.25x | CN¥43.02 Million | CN¥173.88 Million | CN¥43.02 Million | ▼ -50.0% |
| 2010 | 0.49x | CN¥68.79 Million | CN¥139.04 Million | CN¥68.79 Million | ▼ -52.4% |
| 2009 | 1.04x | CN¥86.74 Million | CN¥83.41 Million | CN¥86.74 Million | ▲ +322.2% |
| 2008 | 0.25x | CN¥38.36 Million | CN¥155.77 Million | CN¥38.36 Million | ▼ -90.8% |
| 2007 | 2.67x | CN¥53.74 Million | CN¥20.13 Million | CN¥53.74 Million | ▲ +366.7% |
| 2005 | 0.57x | CN¥149.80 Million | CN¥261.91 Million | CN¥149.80 Million | ▼ -97.6% |
| 2004 | 24.04x | CN¥252.31 Million | CN¥10.50 Million | CN¥252.31 Million | ▲ +212.4% |
| 2003 | 7.70x | CN¥589.20 Million | CN¥76.57 Million | CN¥589.20 Million | ▲ +700.3% |
| 2002 | 0.96x | CN¥180.40 Million | CN¥187.60 Million | CN¥180.40 Million | ▲ +13.2% |
| 2001 | 0.85x | CN¥133.95 Million | CN¥157.73 Million | CN¥133.95 Million | — |